| LGLUX | RGACX | LGLUX / RGACX | |
| Total Expense Ratio | 0.64 | 0.93 | 69% |
| Annual Report Gross Expense Ratio | 0.64 | 0.93 | 69% |
| Fund Existence | 11 years | 24 years | - |
| Gain YTD | 2.817 | 5.397 | 52% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.43B | 357B | 2% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 4.32 | 0.93 | 466% |
| Returns for 3 years | 79.33 | 33.65 | 236% |
| Returns for 5 years | 16.52 | 10.91 | 151% |
| Returns for 10 years | 153.76 | 94.42 | 163% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MRGSX | 27.21 | 0.13 | +0.48% |
| BlackRock Advantage Global R | |||
| PXEAX | 23.77 | 0.09 | +0.38% |
| Impax Global Environmental Markets A | |||
| PMVEX | 33.70 | -0.09 | -0.27% |
| PGIM Quant Solutions Mid-Cap Val R2 | |||
| RYMKX | 78.94 | -0.61 | -0.77% |
| Rydex Russell 2000 1.5x Strategy H | |||
| SHSCX | 45.68 | -0.51 | -1.10% |
| BlackRock Health Sciences Opps Inv C | |||